Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane Kavanagh

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|February 2, 2002
Costs and cognitive disability: modelling the underlying associationsShane Kavanagh, Martin Knapp
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 28, 2004
Drug therapy for Alzheimer's diseaseShane Kavanagh, Patricia Kabathova
Social Science & Medicine (1982)|September 17, 2018
Evidence suggests a need to rethink social capital and social capital interventionsAlan Shiell, Penelope Hawe, Shane Kavanagh
Journal of Opioid Management|September 25, 2010
Burden of opioid-associated gastrointestinal side effects from clinical and economic perspectives: a systematic literature reviewKim Boswell, Winghan Jacqueline Kwong, Shane Kavanagh
Journal of Alzheimer'S Disease : JAD|September 6, 2011
Long-term effects of galantamine on cognitive function in Alzheimer's disease: a large-scale international retrospective studyShane Kavanagh, Bart Van Baelen, Barbara Schäuble
The Annals of Pharmacotherapy|March 4, 2010
Costs of gastrointestinal events after outpatient opioid treatment for non-cancer painWinghan Jacqueline Kwong, Joris Diels, Shane Kavanagh
Drugs & Aging|April 11, 2009
Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trialStephen Aronson, Bart Van Baelen, Shane Kavanagh, et al.
Australian and New Zealand Journal of Public Health|February 5, 2015
Use of pregnancy counselling services in Australia 2007-2012Julia M Shelley, Shane Kavanagh, Melissa Graham, et al.
Health Promotion International|September 27, 2022
Icing or cake? Grant competitions as a model for funding chronic disease prevention in Tasmania, AustraliaVictoria Loblay, Kate Garvey, Alan Shiell, et al.
International Journal of Geriatric Psychiatry|October 9, 2003
The effects of galantamine treatment on caregiver time in Alzheimer's diseaseMary Sano, Gordon K Wilcock, Bart van Baelen, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The British Journal of Psychiatry : the Journal of Mental Science|February 2, 2002
Costs and cognitive disability: modelling the underlying associationsShane Kavanagh, Martin Knapp
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 28, 2004
Drug therapy for Alzheimer's diseaseShane Kavanagh, Patricia Kabathova
Social Science & Medicine (1982)|September 17, 2018
Evidence suggests a need to rethink social capital and social capital interventionsAlan Shiell, Penelope Hawe, Shane Kavanagh
Journal of Opioid Management|September 25, 2010
Burden of opioid-associated gastrointestinal side effects from clinical and economic perspectives: a systematic literature reviewKim Boswell, Winghan Jacqueline Kwong, Shane Kavanagh
Journal of Alzheimer'S Disease : JAD|September 6, 2011
Long-term effects of galantamine on cognitive function in Alzheimer's disease: a large-scale international retrospective studyShane Kavanagh, Bart Van Baelen, Barbara Schäuble
The Annals of Pharmacotherapy|March 4, 2010
Costs of gastrointestinal events after outpatient opioid treatment for non-cancer painWinghan Jacqueline Kwong, Joris Diels, Shane Kavanagh
Drugs & Aging|April 11, 2009
Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trialStephen Aronson, Bart Van Baelen, Shane Kavanagh, et al.
Australian and New Zealand Journal of Public Health|February 5, 2015
Use of pregnancy counselling services in Australia 2007-2012Julia M Shelley, Shane Kavanagh, Melissa Graham, et al.
Health Promotion International|September 27, 2022
Icing or cake? Grant competitions as a model for funding chronic disease prevention in Tasmania, AustraliaVictoria Loblay, Kate Garvey, Alan Shiell, et al.
International Journal of Geriatric Psychiatry|October 9, 2003
The effects of galantamine treatment on caregiver time in Alzheimer's diseaseMary Sano, Gordon K Wilcock, Bart van Baelen, et al.
Pageof 4